Related Experiment Video
Updated: Apr 16, 2026
06:40
In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model
Published on: November 17, 2018
11.9K
An oral redox-sensitive self-immolating prodrug strategy
Tao Sun1, Andrea Morger, Bastien Castagner
1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 3, 8093 Zurich, Switzerland. jleroux@ethz.ch.
Chemical Communications (Cambridge, England)
|February 27, 2015
Summary
Researchers developed a new oral prodrug system using a polymer that releases drugs in the intestine. This redox-sensitive design offers a novel approach for drug delivery and reconversion kinetics.
Area of Science:
- Drug Delivery
- Polymer Chemistry
- Pharmacokinetics
Background:
- Oral drug administration faces challenges with drug solubility and bioavailability.
- Prodrug strategies can improve drug properties but require effective release mechanisms.
Purpose of the Study:
- To develop and evaluate a novel oral prodrug approach utilizing a solubilizing polymer.
- To investigate a redox-sensitive, self-immolating design for drug release in the intestine.
- To study the reconversion kinetics of reducible prodrugs.
Main Methods:
- Conjugation of a solubilizing polymer to a drug molecule.
- Implementation of a redox-sensitive, self-immolating linker system.
- In vitro study of prodrug reconversion kinetics in response to an exogenous agent.
Main Results:
- Successful development of an oral prodrug system with a polymer conjugate.
- Demonstration of drug release triggered by an exogenous agent in the intestine.
- Characterization of reconversion kinetics for three distinct reducible prodrugs.
Conclusions:
- The novel oral prodrug approach shows promise for enhancing drug delivery.
- Redox-sensitive self-immolating linkers are effective for controlled drug release.
- Understanding reconversion kinetics is crucial for optimizing this prodrug strategy.
